SEKISUI Diagnostics News and Resources

SEKISUI Diagnostics has announced the completion of a £15.7 million expansion of its cGMP-certified microbial manufacturing facility in the UK. This new capacity, pending licensing, will enable production of clinical-grade substances for enzyme, protein, antibody fragment, and plasmid-based therapies, including